BIOPHARMA CREDIT PLC ORD USD0.0 (BPCR.L) Financials
BPCR.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 1.3 billion | 4.9 million |
| 2023-03-31 | 1.3 billion | 4.9 million |
| 2022-12-31 | 1.4 billion | 26.3 million |
| 2022-09-30 | 1.4 billion | 26.3 million |
BPCR.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-06-30 | 15.2 million | ? |
| 2023-03-31 | 15.2 million | ? |
| 2022-12-31 | 80.8 million | ? |
| 2022-09-30 | 80.8 million | ? |
BPCR.L Net Income
| Date | Net Income |
|---|---|
| 2023-06-30 | 35.5 million |
| 2023-03-31 | 35.5 million |
| 2022-12-31 | 57.1 million |
| 2022-09-30 | 57.1 million |
BPCR.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 67.9 million | - | - |
| 2023-03-31 | 67.9 million | - | - |
| 2022-12-31 | 120.5 million | - | - |
| 2022-09-30 | 120.5 million | - | - |
BPCR.L Shares Outstanding
BPCR.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | - | - | 3.8 million | - |
| 2023-03-31 | - | - | 3.8 million | - |
| 2022-12-31 | - | - | 14.0 million | - |
| 2022-09-30 | - | - | 14.0 million | - |
BPCR.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | 39.3 million | - |
| 2023-03-31 | 39.3 million | - |
| 2022-12-31 | 71.1 million | - |
| 2022-09-30 | 71.1 million | - |
BPCR.L
Price: $0.88
Dividend Yield: 0.08%
Forward Dividend Yield: 9.11%
Payout Ratio: 61.54%
Dividend Per Share: 0.08 USD
Earnings Per Share: 0.13 USD
P/E Ratio: 7.15
Exchange: LSE
Sector: Financial Services
Industry: Asset Management
Market Capitalization: 10.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 8
DGR3: 17.33%
DGR5: 17.60%